Top compounds associated with response to LINC01420


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0015 1
mRNA BRD-K13185470 CTRPv2 pan-cancer AAC -0.0024 1
mRNA Imatinib CTRPv2 pan-cancer AAC -0.0012 1
mRNA indisulam CTRPv2 pan-cancer AAC -0.001 1
mRNA momelotinib CTRPv2 pan-cancer AAC -0.0011 1
mRNA vincristine CTRPv2 pan-cancer AAC 0.0009 1
mRNA BIRB 0796 CTRPv2 pan-cancer AAC 0.001 1
mRNA BRD-K48334597 CTRPv2 pan-cancer AAC 0.0015 1
mRNA VAF-347 CTRPv2 pan-cancer AAC 0.0011 1
mRNA BRD-K27188169 CTRPv2 pan-cancer AAC -0.0012 1
Download CSV